Volume 18, Issue 3 (Iranian South Medical Journal 2015)                   Iran South Med J 2015, 18(3): 690-700 | Back to browse issues page

PMID: 27695612

XML Persian Abstract Print


Department of Marine Toxinology, The Persian Gulf Marine Biotechnology Research Center, The Persian Gulf Biomedical Research Institute, Bushehr University of Medical Sciences, Bushehr. Iran
Future Studies Group, The Academy of Medical Sciences of the I.R.Iran , inabipour@gmail.com
Abstract:   (5534 Views)

Scenario planning is a process that stimulates imaginative, creative thinking to better prepare an organization for the future. It is also as a tool to promote innovation activities in organizations. Scenario planning may provide alternate futures in which strategies of the organization develop. Very recently, Jay Ogilvy introduced an eight steps scenario planning and strategic forecasting. According to this eight-step process, scenario planning has two major parts: first, choosing which scenario logics to flesh out, a task that comprises the first five steps, and second, telling the actual story, its implications and early indicators, which compromise the remaining steps. In order to identify opportunities and challenges faced by biomedicine sciences there are continually increasing trends for scenario planning in the field. In highly uncertain environments, as are faced in biomedicine sciences, scenario planning can provide a robust, flexible path to navigate. By evaluating the implications of societal, economic and policy impacts of these scenarios, biosciences organizations can determine how to manage a transition to regenerative medicine and personalized medicine, both of which could disrupt current healthcare systems.

Full-Text [PDF 783 kb]   (1825 Downloads)    
Type of Study: Original | Subject: Hospitals and Other Health Facilities
Received: 2015/04/22 | Accepted: 2015/07/9 | Published: 2015/06/28

Rights and Permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.